PTP4A3 and colorectal carcinoma: Multiple groups have verified that PRL-3 exhibited a significant increase in liver metastases of CRC, as well as in secondary CRC lesions discovered in the lung, brain, ovary, peritoneum, and lymph nodes [34,91,92].